[Retracted] Predictive Significance of High-Sensitivity C-Reactive Protein Combined with Homocysteine for Coronary Heart Disease in Patients with Anxiety Disorders

Table 1

Characteristics between patients with anxiety disorders complicated with CHD or not.

Parameters	Patients with anxiety disorders complicated with CHD ()	Patients with anxiety disorders alone ()	value
HAMA score	16.5 (15, 18.75)	16 (15, 19.5)	0.702^a
Male	41 (64.1%)	36 (40.4%)	0.004^b
Age (years)	64 (58.0, 69.75)	62.0 (56.0, 65.0)	0.024^a
Smoking	23 (35.9%)	14 (15.7%)	0.004^b
Diabetes mellitus	23 (35.9%)	15 (16.9%)	0.007^b
Hypertension	42 (65.6%)	39 (43.8%)	0.008^b
BMI (kg/m^2)	25.31 (23.66, 27.75)	24.21 (22.85, 26.53)	0.063^a
IL-6 (≥3.5 pg/mL)	25 (39.1%)	8 (9.0%)	<0.001^b
hs-CRP (mg/L)	1.76 (0.70, 4.28)	0.84 (0.45, 1.66)	<0.001^a
Hcy (μmol/L)	11.49 (9.66, 16.28)	10.08 (8.42, 11.43)	<0.001^a
Fibrinogen (g/L)			0.459^c
D-dimer (g/L)	0.24 (0.19, 0.29)	0.22 (0.18, 0.26)	0.112^a
Cortisol (nmol/L)			0.894^c
Norepinephrine (nmol/L)	0.41 (0.26, 0.53)	0.37 (0.29, 0.52)	0.814^a
tCholesterol (mmol/L)	5.10 (4.52, 5.74)	4.97 (4.20, 5.60)	0.155^a
HDL-C (mmol/L)			0.222^c
LDL-C (mmol/L)		2.86 ± 0.87	0.314^c
Triglyceride (mmol/L)	1.56 (1.12, 2.20)	1.39 (0.98, 2.17)	0.141^a
Lp(a) (mmol/L)	152.58 (58.92, 294.15)	107.35 (51.09, 208.87)	0.207^a
ApoB (mmol/L)			0.104^c
Creatinine (μmol/L)	64.15 (55.8, 71.78)	60.1 (55.1, 68.7)	0.116^a

Notes: data are shown as , median with IQR, or absolute number (percentage). ^aStudent -test; ^bchi-square test; ^cMann-Whitney test. Abbreviations: CHD: coronary heart disease; HAMA: Hamilton Anxiety Scale; BMI: body mass index; IL-6: interleukin-6; hs-CRP: high-sensitivity C-reactive protein; Hcy: homocysteine; tCholesterol: total cholesterol; HDL-C: high-density lipoprotein cholesterol; LDL-C: low-density lipoprotein cholesterol; Lp(a): lipoprotein (a); ApoB: apolipoprotein B.